Notifications
Back

Life Science Research, Development,
and Commercialization Company


JNPMEDI provides the most efficient and tailored solutions at
every stage of RDC for customers in the life sciences industry.



Life Science Research, Development,
and Commercialization Company


JNPMEDI provides the most efficient and tailored solutions at every stage of RDC for customers in the life sciences industry.



ABOUT JNPMEDI

In 2020, JNPMEDI was founded with the aim of enhancing Korea's globally recognized medical infrastructure by leveraging digital technologies such as blockchain and cloud computing through a cutting-edge medical data platform.


We launched the clinical trial data management solution, Maven Clinical Cloud,
which significantly contributed to the digital transformation of the clinical trial industry.
In 2024, JNPMEDI expanded into professional services, integrating digital technologies into all aspects of our customers' business beyond just clinical trial stages, marking another milestone in its growth.

Now, we are building networks with diverse clients and partners both domestically and internationally, progressing towards becoming a global enterprise.

The Infrastructure
for a Healthier Future


We are building the foundation/infrastructure for a healthier future. 


We create the foundation for a broader world to benefit from the healthier future through digital innovation in life sciences. 

mobile background
Core Values at JNPMEDI Inc. 

CLIENT VALUE FIRST

We continuously provide value through our top-tier solutions and services, enabling our healthcare clients to achieve their goals. 

INTEGRITY AT HEART

We prioritize ethics and integrity in all decision-making processes. We will always take responsibility for our words and actions, no matter the situation. 

SOCIALLY RESPONSIBLE

We are dedicated to improving the healthcare environment through continuous technological development, fulfilling our social responsibility to ensure that all of humanity can benefit. 

More and more clients are partnering with JNPMEDI.

ABOUT JNPMEDI

In 2020, JNPMEDI was founded with the aim of enhancing Korea's globally recognized medical infrastructure 

by leveraging digital technologies such as blockchain and cloud computing
through a cutting-edge medical data platform.


We launched the clinical trial data management solution, Maven Clinical Cloud,
which significantly contributed to the digital transformation of the clinical trial industry.
In 2024, JNPMEDI expanded into professional services, integrating digital technologies into all aspects
of our customers' business beyond just clinical trial stages, marking another milestone in its growth.

Now, we are building networks with diverse clients and partners
both domestically and internationally, progressing towards becoming a global enterprise.


The infrastructure for a healthier future


We are building the foundation/infrastructure for a healthier future. 


We create the foundation for a broader world to benefit from the healthier future 
through digital innovation in life sciences. 


Core Values at JNPMEDI Inc.

CLIENT VALUE FIRST

We continuously provide value through our top-tier solutions and services, enabling our healthcare clients to achieve their goals.

INTEGRITY AT HEART

We prioritize ethics and integrity in all decision-making processes. We will always take responsibility for our words and actions, no matter the situation.

SOCIALLY RESPONSIBLE

We are dedicated to improving the healthcare environment through continuous technological development, fulfilling our social responsibility to ensure that all of humanity can benefit.

240+

Clinical Trial Site

4K+

Solution Usage

30K+

Subject Enrollment

4M+

Data Records

VISION 2.0

 ______

LIFE SCIENCE
ENABLEMENT PLATFORM


We support the success of our clients' life sciences business.

VISION 1.0

 ______

NO LONGER CLINICAL SCIENCE
BUT DATA SCIENCE


We Maximize efficiency through the digitalization of the clinical trial industry.


Experts from various fields come together
to support the success of our clients. 

Experts from various fields come together
to support the success of our clients.

• Univ. of Washington B.S. in Applied Physics

• Former Chief Strategy Officer, Dunamu and Lambda256

• Former Management Consultant, Accenture and IBM


• Hanyang University B.S. in Computer Engineering

• Former Development Lead, Dunamu and Lambda256 

• Former Development Lead, eBay Korea and Futurewiz


• Yonsei University Severance Hospital Certified Clinical Pharmacologist 

• Former CEO, DreamCIS and Seoul CRO

• Former Medical Director, GE Healthcare and Novartis


• Seoul National University B.S. in Engineering, M.S. in Dentistry, Ph.D. candidate in Medical Informatics 

• Former Healthcare Team Lawyer, Kim&Chang

• Former Korean Bar Association Director


• Sookmyung Women's Univ. B.S. in Pharmacy

• Former Regional Project Manager, Boehringer-Ingelheim

• Former Head of Clin Ops, Asia Feasibility Lead, Gilead Science


• Yonsei University B.S. in Nursing/B.S. in Psychology

• Former Medical Device Clinical Director, Synex

• Former Strategy Director, Olive Healthcare


• Catholic University M.S. in Biostatistics

• Former Head of DM/IT Department, Seoul CRO

• Former DMM, DreamCIS


• Ewha Womans University B.S. in Nursing, Seoul National University M.S. in Public Health
• Former BD Director, LSK Global PS
• Former DQM Team Leader/DMM, LSK Global PS


• Catholic University M.S. in Biostatistics

• Former DM Director, Novotech

• Former BS Director, DreamCIS and Korea Otsuka


• Ewha Womans University B.A. in English Literature, Yonsei University M.S. in Human Resources Development

• Former APAC Senior Talent Partner, IBM

•Former HR Manager, PwC


• Korea University B.S. in Food and Nutrition

•Former Medtech Ethicon Territory Sales Manager, Johnson&Johnson

• Former Assistant Product Manager, RLAP


• Kwangwoon University B.A. in Korean Language&Literature and Journalism&Broadcasting
• Former Sales Manager, AstraZeneca and Daewoong Pharmaceutical

• Former BD Team Leader/BDM, LSK Global PS


• Ohio State University B.S. in Biology, University of Michigan M.S. in Biostatistics 

• Former Medical Device Devision Biostat Reviewer, MFDS

•Former Cancer Screening Group Biostatistician, Lunit


• Dongguk University M.S. in Medical Device Industry

• Former Medical Device R&D Department Senior Project Manager, Synex

• Former RA Team leader, Genewel


• Sungkyunkwan University M.S. in Management of Technology

• Former Digital Innovation Department Manager, KB Securities

• Former Management Consultant, Accenture and IBM


• Rutgers University B.S. in Biotechnology, Sungkyunkwan University M.S. in Clinical Epidemiology

• Former R&D Researcher, Pfizer New York and Siemens New York

• Former Strategy Development, Chong Kun Dang and CHA Biotech